Search

Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS

Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 310-314
Author(s): A. Mario Marcondes, Aravind Ramakrishnan, H. Joachim Deeg

Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control

Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 303-309
Author(s): Junya Kuroda, Masafumi Taniwaki

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 120-133
Author(s): Bernhard A. Muller

Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 5 Year: 2009 Page: 675-689
Author(s): K. V. Gleixner, M. Mayerhofer, A. Vales, A. Gruze, G. Hormann, S. Cerny-Reiterer, E. Lackner, E. Hadzijusufovic, H. Herrmann, A. K. Iyer, M.-T. Krauth, W. F. Pickl, B. Marian, R. Panzer-Grumayer, C. Sillaber, H. Maeda, C. Zielinski, P. Valent

Exposure of B Cell Chronic Lymphocytic Leukemia (B-CLL) Cells to Nutlin-3 Induces a Characteristic Gene Expression Profile, which Correlates with Nutlin-3-Mediated Cytotoxicity (Supplementry Table)

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 510-518
Author(s): G. Zauli, M. G. di Iasio, P. Secchiero, M. Dal Bo, D. Marconi, R. Bomben, G. Del Poeta, V. Gattei

The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials

Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 243-255
Author(s): Hanne Fredly, Elisabeth Ersvaer, Camilla Stapnes, Bjorn Tore Gjertsen, Oystein Bruserud

Fcγ Receptor 1 (CD64), a Target Beyond Cancer

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 2712-2718
Author(s): T. Thepen, M. Huhn, G. Melmer, M. K. Tur, S. Barth

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 2652-2664
Author(s): Robert J. Kreitman

Clofarabine as a Novel Nucleoside Analogue Approved to Treat Patients with Haematological Malignancies: Mechanism of Action and Clinical Activity

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9 Issue: 7 Year: 2009 Page: 805-812
Author(s): Ewa Lech-Maranda, Anna Korycka, Tadeusz Robak

Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 66-76
Author(s): Dariusz Pytel, Tomasz Sliwinski, Tomasz Poplawski, Deborah Ferriola, Ireneusz Majsterek